nitroblue tetrazolium has been researched along with Kahler Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Korotkiĭ, VV; Kotsaĭ, BR; Loginskiĭ, VE | 1 |
| Kaufman, S; Peller, S; Yona, R | 1 |
2 other study(ies) available for nitroblue tetrazolium and Kahler Disease
| Article | Year |
|---|---|
[Value of the nitroblue tetrazolium reduction test for diagnosis of infectious complications in lymphoroliferative diseases].
Topics: Evaluation Studies as Topic; Humans; Infections; Leukemia, Lymphoid; Lymphoma; Multiple Myeloma; Nitroblue Tetrazolium; Tetrazolium Salts; Waldenstrom Macroglobulinemia | 1978 |
Functions of polymorphonuclear (PMN) leukocytes of patients with lymphoproliferative diseases.
Topics: Adolescent; Adult; Alkaline Phosphatase; Chemotaxis, Leukocyte; Child; Child, Preschool; Hodgkin Disease; Humans; Lymphoma; Lymphoproliferative Disorders; Middle Aged; Multiple Myeloma; Neutrophils; Nitroblue Tetrazolium; Oxidation-Reduction; Phagocytosis | 1985 |